Trials and tribulations of immunotherapy as a treatment option for patients with squamous cell carcinoma of the head and neck

Author： Young M.  

Publisher： Springer Publishing Company

ISSN： 0340-7004

Source： Cancer Immunology, Immunotherapy, Vol.53, Iss.5, 2004-05, pp. : 375-382

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Compliance and toxicity of the hypoxic radiosensitizer nimorazole in the treatment of patients with head and neck squamous cell carcinoma (HNSCC)

By Metwally Mohamed A. Hassan   Frederiksen Katrine Diemer   Overgaard Jens  

Acta Oncologica, Vol. 53, Iss. 5, 2014-05 ,pp. : 654-661

Informa Healthcare

Access to resources Recommend Favorite

Bcl-2 Targeted-Therapy for the Treatment of Head and Neck Squamous Cell Carcinoma

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 6, Iss. 1, 2011-01 ,pp. : 45-57

Bentham Science Publishers

Access to resources Recommend Favorite

Retinoic Acid Concentrations in Patients With Squamous Cell Carcinoma of the Head and Neck

By Wahlberg P.   Fex G.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 366-367

Elsevier

Access to resources Recommend Favorite

Gene profiling in squamous cell carcinoma of the head and neck

By Akervall Jan  

Cancer and Metastasis Reviews, Vol. 24, Iss. 1, 2005-01 ,pp. : 87-94

Springer Publishing Company

Access to resources Recommend Favorite

Cetuximab in squamous cell carcinoma of the head and neck

By Hitt Ricardo   Martín Patricia   Hidalgo Manuel  

Future Oncology, Vol. 2, Iss. 4, 2006-08 ,pp. : 449-457

Future Medicine

Access to resources Recommend Favorite